Literature DB >> 33846432

Transcutaneous auricular vagus nerve stimulation induces stabilizing modifications in large-scale functional brain networks: towards understanding the effects of taVNS in subjects with epilepsy.

Randi von Wrede1, Thorsten Rings2,3, Sophia Schach2, Christoph Helmstaedter2, Klaus Lehnertz2,3,4.   

Abstract

Transcutaneous auricular vagus nerve stimulation (taVNS) is a novel non-invasive brain stimulation technique considered as a potential supplementary treatment option for subjects with refractory epilepsy. Its exact mechanism of action is not yet fully understood. We developed an examination schedule to probe for immediate taVNS-induced modifications of large-scale epileptic brain networks and accompanying changes of cognition and behaviour. In this prospective trial, we applied short-term (1 h) taVNS to 14 subjects with epilepsy during a continuous 3-h EEG recording which was embedded in two standardized neuropsychological assessments. From these EEG, we derived evolving epileptic brain networks and tracked important topological, robustness, and stability properties of networks over time. In the majority of investigated subjects, taVNS induced measurable and persisting modifications in network properties that point to a more resilient epileptic brain network without negatively impacting cognition, behaviour, or mood. The stimulation was well tolerated and the usability of the device was rated good. Short-term taVNS has a topology-modifying, robustness- and stability-enhancing immediate effect on large-scale epileptic brain networks. It has no detrimental effects on cognition and behaviour. Translation into clinical practice requires further studies to detail knowledge about the exact mechanisms by which taVNS prevents or inhibits seizures.

Entities:  

Year:  2021        PMID: 33846432     DOI: 10.1038/s41598-021-87032-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  40 in total

1.  Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study.

Authors:  Zhibin Chen; Martin J Brodie; Danny Liew; Patrick Kwan
Journal:  JAMA Neurol       Date:  2018-03-01       Impact factor: 18.302

2.  Transcutaneous vagal nerve stimulatio (t-VNS): An adjunctive treatment option for refractory epilepsy.

Authors:  Giuseppina Barbella; Isabella Cocco; Elena Freri; Guia Marotta; Elisa Visani; Silvana Franceschetti; Marina Casazza
Journal:  Seizure       Date:  2018-06-18       Impact factor: 3.184

3.  Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial.

Authors:  Hermann Stefan; Gernot Kreiselmeyer; Frank Kerling; Katrin Kurzbuch; Christophe Rauch; Marcel Heers; Burkhard S Kasper; Thilo Hammen; Martina Rzonsa; Elisabeth Pauli; Jens Ellrich; Wolfgang Graf; Rüdiger Hopfengärtner
Journal:  Epilepsia       Date:  2012-05-03       Impact factor: 5.864

4.  Early identification of refractory epilepsy.

Authors:  P Kwan; M J Brodie
Journal:  N Engl J Med       Date:  2000-02-03       Impact factor: 91.245

5.  Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response.

Authors:  Robert E Elliott; Amr Morsi; Stephen P Kalhorn; Joshua Marcus; Jonathan Sellin; Matthew Kang; Alyson Silverberg; Edwin Rivera; Eric Geller; Chad Carlson; Orrin Devinsky; Werner K Doyle
Journal:  Epilepsy Behav       Date:  2010-12-08       Impact factor: 2.937

Review 6.  Electrical stimulation of cranial nerves in cognition and disease.

Authors:  Devin Adair; Dennis Truong; Zeinab Esmaeilpour; Nigel Gebodh; Helen Borges; Libby Ho; J Douglas Bremner; Bashar W Badran; Vitaly Napadow; Vincent P Clark; Marom Bikson
Journal:  Brain Stimul       Date:  2020-02-23       Impact factor: 8.955

Review 7.  Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Authors:  George L Morris; David Gloss; Jeffrey Buchhalter; Kenneth J Mack; Katherine Nickels; Cynthia Harden
Journal:  Neurology       Date:  2013-08-28       Impact factor: 9.910

8.  Transcutaneous Vagus Nerve Stimulation (tVNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial (cMPsE02).

Authors:  S Bauer; H Baier; C Baumgartner; K Bohlmann; S Fauser; W Graf; B Hillenbrand; M Hirsch; C Last; H Lerche; T Mayer; A Schulze-Bonhage; B J Steinhoff; Y Weber; A Hartlep; F Rosenow; H M Hamer
Journal:  Brain Stimul       Date:  2016-01-20       Impact factor: 8.955

Review 9.  The anatomical basis for transcutaneous auricular vagus nerve stimulation.

Authors:  Mohsin F Butt; Ahmed Albusoda; Adam D Farmer; Qasim Aziz
Journal:  J Anat       Date:  2019-11-19       Impact factor: 2.610

10.  Efficacy and Safety of Treatment with Transcutaneous Vagus Nerve Stimulation in 17 Patients with Refractory Epilepsy Evaluated by Electroencephalogram, Seizure Frequency, and Quality of Life.

Authors:  Aihua Liu; Peijing Rong; Li Gong; Lu Song; Xian Wang; Liping Li; Yuping Wang
Journal:  Med Sci Monit       Date:  2018-11-23
View more
  8 in total

1.  Auricular vagus nerve stimulator for closed-loop biofeedback-based operation.

Authors:  Babak Dabiri; Klaus Zeiner; Arnaud Nativel; Eugenijus Kaniusas
Journal:  Analog Integr Circuits Signal Process       Date:  2022-05-10       Impact factor: 1.321

2.  Transcutaneous Auricular Vagus Nerve Stimulation Differently Modifies Functional Brain Networks of Subjects With Different Epilepsy Types.

Authors:  Randi von Wrede; Thorsten Rings; Timo Bröhl; Jan Pukropski; Sophia Schach; Christoph Helmstaedter; Klaus Lehnertz
Journal:  Front Hum Neurosci       Date:  2022-06-23       Impact factor: 3.473

3.  Modifications of Functional Human Brain Networks by Transcutaneous Auricular Vagus Nerve Stimulation: Impact of Time of Day.

Authors:  Randi von Wrede; Timo Bröhl; Thorsten Rings; Jan Pukropski; Christoph Helmstaedter; Klaus Lehnertz
Journal:  Brain Sci       Date:  2022-04-26

4.  Electrodermal Activity Biofeedback Alters Evolving Functional Brain Networks in People With Epilepsy, but in a Non-specific Manner.

Authors:  Sophia Schach; Thorsten Rings; Madeleine Bregulla; Juri-Alexander Witt; Timo Bröhl; Rainer Surges; Randi von Wrede; Klaus Lehnertz; Christoph Helmstaedter
Journal:  Front Neurosci       Date:  2022-03-03       Impact factor: 4.677

5.  Immediate Modulation of Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Treatment-Resistant Depression: A Resting-State Functional Magnetic Resonance Imaging Study.

Authors:  Jifei Sun; Yue Ma; Zhongming Du; Zhi Wang; Chunlei Guo; Yi Luo; Limei Chen; Deqiang Gao; Xiaojiao Li; Ke Xu; Yang Hong; Fengquan Xu; Xue Yu; Xue Xiao; Jiliang Fang; Xiaobing Hou
Journal:  Front Psychiatry       Date:  2022-07-01       Impact factor: 5.435

6.  Stimulation-related modifications of evolving functional brain networks in unresponsive wakefulness.

Authors:  Christoph Helmstaedter; Thorsten Rings; Lara Buscher; Benedikt Janssen; Sara Alaeddin; Vanessa Krause; Stefan Knecht; Klaus Lehnertz
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

7.  Transcutaneous auricular vagus nerve stimulation in poststroke cognitive impairment: protocol for a randomised controlled trial.

Authors:  Zhen-Dong Li; Hang-Jian Qiu; Xiao-Qian Wang; Cheng-Cheng Zhang; Yue-Juan Zhang
Journal:  BMJ Open       Date:  2022-10-05       Impact factor: 3.006

8.  Non-Invasive Transcutaneous Vagus Nerve Stimulation for the Treatment of Fibromyalgia Symptoms: A Study Protocol.

Authors:  Andrés Molero-Chamizo; Michael A Nitsche; Armin Bolz; Rafael Tomás Andújar Barroso; José R Alameda Bailén; Jesús Carlos García Palomeque; Guadalupe Nathzidy Rivera-Urbina
Journal:  Brain Sci       Date:  2022-01-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.